Physiologically-based pharmacokinetic simulation modelling
The DOI matches its Crossref record; 111 of the 115 references it cites were found in a registry or an index.
Abstract
Drug selection is now widely viewed as an important and relatively new, yet largely unsolved, bottleneck in the drug discovery and development process. In order to achieve an efficient selection process, high quality, rapid, predictive and correlative ADME models are required in order for them to be confidently used to support critical financial decisions. Systems that can be relied upon to accurately predict performance in humans have not existed, and decisions have been made using tools whose capabilities could not be verified until candidates went to clinical trial, leading to the high failure rates historically observed. However, with the sequencing of the human genome, advances in proteomics, the anticipation of the identification of a vastly greater number of potential targets for drug discovery, and the potential of pharmacogenomics to require individualized evaluation of drug kinetics as well as drug effects, there is an urgent need for rapid and accurately computed pharmacokinetic properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“first because referencing practices are suboptimal (compare e.g. the data and figures from [5, 72, 73, 77].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [72]
In the citing paper
“Several scatterplots of pharmacokinetic parameters for a set of drugs in animals versus humans show low correspondence rates, i.e. they do not show an apparent relationship between animal and human data (e.g. [72, 73].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [72]
Citations
Cites
1 retracted
Chang, G., & Roth, C. B. (2001) · Science · doi:10.1126/science.293.5536.1793 · Cited by 619
RetractedDrug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Arkin, A., Ross, J., & McAdams, H. H. (1998) · Genetics · doi:10.1093/genetics/149.4.1633 · Cited by 1,490
Artursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
E-CELL: software environment for whole-cell simulation
Tomita, M., Hashimoto, K., Takahashi, K., Shimizu, T. S., Matsuzaki, Y., Miyoshi, F., Saito, K., Tanida, S., Yugi, K., Venter, J. C., et al. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.1.72 · Cited by 764
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9804011 · Cited by 627
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells
Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., & Tokuda, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00076-2 · Cited by 568
Research works printed but not linked: 9
- Peakman, 2001, Putting the code to work: The promise of pharmacogenetics and pharmacogenomics, Drug Discovery World, 2, 35
- PhRMA. Why do drugs cost so much? PhRMA, Washington DC, 2000, pp. 1–22.
- Leahy, 1997, Pharmacokinetics in early drug research, ATLA, 25, 17
- Dearden, 1984, Mathematical modelling of the drug transport process— incorporation of realistic transfer rate constants and a dissolution step QSAR and strategies in the design of bioactive compounds, Pharm. Res., 1, 328
- A. Regalado. Re-engineering drug development 1: Simulating clinical trials, Start-up, Windover Information Inc., Vol. January, 1998, pp. 13–18.
- Sale, 2001, Modelling and simulation in drug development, promise and reality, Drug Discov. World, 2, 47
- Brodie, 1964, Of mice, microsomes, and men, Pharmacologist, 6, 12
- Pickering, 2001, Creating a pharmacological profile, Drug Disc. and Dev., 4, 53
- Lindpaintner, 2001, Pharmacogenetics: A review of concepts and contents, Drug Discovery World, 2, 21
Cited by
Assessing the performance of amorphous solid dispersions
Newman, A., Knipp, G., & Zografi, G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23031 · Cited by 406
Jamei, M., Dickinson, G. L., & Rostami-Hodjegan, A. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.53 · Cited by 368
“The model is based on the work of Grass 137,138) and is very similar to the CAT model.”
MethodPhysiologically Based Pharmacokinetic Modeling of Nanoparticles
Li, M., Al-Jamal, K. T., Kostarelos, K., & Reineke, J. (2010) · ACS Nano · doi:10.1021/nn1018818 · Cited by 351
“The principles of PBPK models are described briefly and more detailed descriptions are referred to other reviews.(29,30) Emphasis will be placed on the factors to be considered for model development and application and the significance to nanoparticles.”
BackgroundAnimal to human translation: a systematic scoping review of reported concordance rates
Leenaars, C. H. C., Kouwenaar, C., Stafleu, F. R., Bleich, A., Ritskes-Hoitinga, M., De Vries, R. B. M., & Meijboom, F. L. B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1976-2 · Cited by 314
Lennernäs, H., & Abrahamsson, B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055263 · Cited by 215
“However, simple physicochemical descriptors of solubility and permeability must probably be assembled into, and validated in, more physiological-based models to be able to accurately predict human intestinal absorption (Agoram et al 2001; Grass & Sinko 2002; Rowland et al 2004).”
Background
Metadata
- Authors
- Grass, G. M., & Sinko, P. J.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Grass, George M
- ORCID
- Sinko, Patrick J
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 54
- Issue
- 3
- Pages
- 433-451
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1979813244
- Cited by
- 160
- References
- 115
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 4 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 10 · 2012: 5
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- physiologically based pharmacokinetic modelling, ADME prediction, drug selection, drug discovery, drug development, pharmacogenomics, drug target identification
- MeSH terms
- Animals, Computer Simulation, Drug Industry, Pharmaceutical Preparations, Humans, Models, Biological, Pharmacokinetics, Computational Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physiologically-based pharmacokinetic simulation modelling. https://app.cochat.ai/papers/10.1016/s0169-409x(02)00013-3
- The paper
- Grass, G. M., & Sinko, P. J. (2002). Physiologically-based pharmacokinetic simulation modelling. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(02)00013-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.